3rd Circ. Stays Provigil Pay-For-Delay Trial During Cert. Appeal
The Third Circuit agreed Monday to stay an upcoming trial in a class action accusing Mylan and Ranbaxy Laboratories of inking pay-for-delay deals with Cephalon to keep generic versions of narcolepsy...To view the full article, register now.
Already a subscriber? Click here to view full article